Although the second messenger adenosine 3 ,5 -cyclic monophosphate (cAMP) activates protein kinase A (PKA), recent studies provide compelling evidence for an alternative mechanism of cAMP signal transduction, one that involves cAMP-regulated guanine nucleotide exchange factors (cAMP-GEF) known as Epacs (the Exchange Protein directly Activated by Cyclic AMP; de Rooij et al. 1998; Kawasaki et al. 1998) . The analysis of Epac-mediated signal transduction has been facilitated by the development of Epac-selective cyclic AMP analogues (ESCAs). These synthetic analogues of cAMP incorporate a 2 -O-alkyl substitution on the ribose ring of cAMP, as in 2 -O-Me-cAMP, a modification that impairs their ability to activate PKA, while leaving intact their ability to activate Epac (Christensen et al. 2003 ). An ESCA that also incorporates a hydrophobic parachlorophenylthio (pCPT) substitution on the adenine moiety of cAMP is 8-pCPT-2 -O-Me-cAMP (Enserink et al. 2002) . It is cell permeant and when it is applied to living cells, it stimulates Ca 2+ signalling and exocytosis in multiple cell types (Holz et al. , 2008a . We recently reported that 2 -O-Me-cAMP and 8-pCPT-2 -O-Me-cAMP inhibit a sulphonylurea-sensitive K + current in pancreatic β-cells through an as yet to be determined mechanism . In the present study we applied the methods of single channel analysis to human pancreatic β-cells and a rat β-cell line (INS-1 cells; a cell line that expresses Epac and K ATP channels; Leech et al. 2000; Moritz et al. 2001) in order to investigate the nature of this effect.
ATP-sensitive K + channels (K ATP channels) expressed in β-cells are hetero-octamers comprising Kir6.2 and sulphonylurea receptor-1 (SUR1) subunits (Ashcroft, 2005) . Kir6.2 constitutes the K + -selective pore-forming subunit, whereas SUR1 acts as an allosteric regulator of Kir6.2 gating (Nichols, 2006) . Although ATP interacts directly with Kir6.2 to close the channel, the binding of J Physiol 586.5 Mg-ADP to SUR1 opens the channel. Intriguingly, new studies demonstrate direct interactions of SUR1 with Epac proteins, a finding first reported by Seino and coworkers (Ozaki et al. 2000) . For example, when expressed in HEK cells, both Epac1 and Epac2 interact with full-length SUR1 , and for Epac2 this interaction appears to be mediated by nucleotide-binding fold-1 (NBF-1) of SUR1 (Shibasaki et al. 2004a,b; Bryan et al. 2007 ). Since cAMP-elevating agents inhibit β-cell K ATP channel activity (Holz & Habener, 1992; Holz et al. 1993; Barnett et al. 1994; Gromada et al. 1998; He et al. 1998; Suga et al. 2000; Ding et al. 2001; Light et al. 2002; Kang et al. 2006) , we have proposed that the interaction of Epac with SUR1 confers cAMP-dependent regulation of this channel's function Kang et al. 2006) .
In the present study we sought to determine if the interaction of cAMP with Epac might regulate the sensitivity of K ATP channels to ATP. Consistent with this concept, we now demonstrate that in human β-cells and rat INS-1 cells, 2 -O-Me-cAMP sensitizes K ATP channels to the inhibitory effect of ATP, thereby producing a left-shift of the concentration-response relationship describing ATP-dependent inhibition of K ATP channel activity. We also report that Sp-8-pCPT-2 -O-Me-cAMPS, a cyclic nucleotide phosphodiesterase (PDE) resistant ESCA, produces a decrease of K ATP channel activity, thereby demonstrating that the inhibitory actions of ESCAs reported here are unlikely to be a consequence of their hydrolysis to bioactive derivatives of adenosine, a confounding effect observed in other cell types (Laxman et al. 2006) . In summary, the new findings presented here demonstrate that there exists in β-cells a novel form of ion channel modulation in which the ATP sensitivity of K ATP channels is regulated by Epac.
Methods

Cell culture
With informed consent for tissue use for research, human islets of Langerhans were obtained from cadaver donors. They were provided, with safeguards for donor anonymity, by the Islet Cell Resource Service of the National Institutes of Health, National Center for Research Resources. (http://icr.coh.org/). Approval for the use of human islets in the laboratory of G. G. Holz was granted by the Institutional Review Board of New York University School of Medicine. Single cell suspensions of human islet cells were prepared by digestion of islets with trypsin-EDTA, and single cells were plated onto glass coverslips (25CIR-1; Fisher Scientific) coated with 1 mg ml −1 concanavalin A (type V; Sigma-Aldrich, St Louis, MO, USA). Cell cultures were maintained in a humidified incubator (95% air, 5% CO 2 ) at 37
• C in CMRL-1066 modified culture medium (Mediatech, Inc., Herndon, VA, USA; cat. no. 99-603-CV) containing 10% (v/v) fetal bovine serum (FBS). β-Cells were identified by fluorescence microscopy after infection of the cultures with adenovirus directing expression of enhanced yellow fluorescent protein (EYFP) under the control of the rat insulin 2 gene promoter (Kang et al. 2003) . INS-1 cells (passages 70-90) were obtained from Dr C. B. Wollheim (University Medical Center, Geneva, Switzerland). INS-1 cells are an immortalized cell line derived from a radiation-induced insulinoma of rat pancreas (Asfari et al. 1992) . INS-1 cells were maintained in RPMI 1640 medium containing 10 mm Hepes, 11.1 mm glucose, 10% FBS, 100 U ml −1 penicillin G, 100 μg ml −1 streptomycin, 2.0 mm l-glutamine, 1.0 mm sodium pyruvate, and 50 μm 2-mercaptoethanol (Asfari et al. 1992; Chepurny & Holz, 2007) . INS-1 cells were passaged by trypsinization and subcultured once a week. Reagents for INS-1 cell culture were obtained from Invitrogen Life Technologies (Rockville, MD, USA).
Measurement of single channel K ATP currents
For the detection of single K ATP channel currents in inside-out patches, pipettes pulled from borosilicate glass were fire-polished and back-filled with a solution containing (mm): 140 KCl, 1.0 MgCl 2 , 2.0 CaCl 2 , 5 Hepes (300 mosmol l −1 ; pH 7.3). Patches were excised into a bath solution containing (mm): 70 K 2 SO 4 , 2.0 MgCl 2 , 0.1 CaCl 2 , 1.1 EGTA, 0.2 GTP, 5 Hepes, and the indicated [ATP] . The free [Ca 2+ ] of this solution was 160 nm, the pH was 7.3, and the osmolarity was 300 mosmol l −1 . The patch potential was maintained at −100 mV in order to measure inward K + currents through K ATP channels. Data were acquired using an Axopatch 200B amplifier under the control of pCLAMP v.9.2 (Molecular Devices, Sunnyvale, CA, USA). Channel currents were low-pass filtered at 1 kHz (8-pole Bessel filter) and digitized at 5 or 10 kHz. All experiments were performed at 22-26
• C on the stage of an inverted microscope.
Analysis of single channel K ATP currents
K ATP channel activity was determined prior to, during and following recovery from the application of test substances. Channel activity was calculated as the value NP o from 20 to 40 s intervals of data, where N is the number of channels active in the patch, and P is the probability that a channel is open. Values of NP o were determined by constructing all-points amplitude histograms of channel activity (bin width 0.5 pA) using pCLAMP v.9.2. Gaussian curves were superimposed on the histograms using Origin 7.5 (OriginLab Corp., Northampton, MA, USA). For studies in which values of NP o were compared amongst groups of patches exposed to different test solutions, statistical significance of the results was evaluated using SigmaStat software (Systat Software, San Jose, CA, USA) in order to perform one-way analysis of variance (ANOVA) with Dunnett's post hoc test for comparing control and test groups. Differences amongst the groups were considered significant at P < 0.05. Best-fits of the dose-response relationships describing the actions of 2 -O-Me-cAMP or ATP to inhibit K ATP channel activity were obtained using the nonlinear regression curve-fitting module of SigmaPlot v.10.0 (Systat Software). The data were fitted to the Hill equation: 
Results
-O-Me-cAMP inhibits K ATP channel activity in INS-1 cells
When the inner surfaces of excised patches were exposed to a fixed concentration of ATP (10 μm), the Epac-selective cAMP analogue 2 -O-Me-cAMP (50 μm) inhibited INS-1 cell K ATP channel activity in 16 of 20 patches (Fig. 1A) . Measurement of NP o values deduced from an all-points amplitude histogram (Fig. 1B) demonstrated that 2 -O-Me-cAMP reduced channel activity by 94 ± 5% in patches in which an effect of the ESCA was observed (Fig. 1C ). This action of the ESCA was unlikely to be a consequence of a direct channel block because in 4 of 20 patches exhibiting K ATP channel activity, 2 -O-Me-cAMP was without action whereas 1 mm ATP remained effective (data not shown). The inhibitory action of 2 -O-Me-cAMP developed over 5-10 s, longer than that measured for the onset of inhibition by ATP, despite the fact that the test solution containing 2 -O-Me-cAMP was delivered to the patch within 200 ms. With continual application of 2 -O-Me-cAMP, little or no desensitization was evident.
Upon washout of 2 -O-Me-cAMP, partial recovery of channel activity was observed within 10-30 s, after which the effect of 2 -O-Me-cAMP was repeatable. Determination of the cumulative dose-response relationship demonstrated the potency of 2 -O-Me-cAMP in this assay ( Fig. 2A and B) . In the presence of 10 μm ATP, the concentration of 2 -O-Me-cAMP producing a 50% inhibition of channel activity (IC 50 ) was 12 μm, a value in agreement with the reported affinity of 2 -O-Me-cAMP for Epac1 (Christensen et al. 2003) . The action of 2 -O-Me-cAMP was mimicked by a high concentration (300 μm) of cAMP ( Fig. 3A-C) , whereas channel activity was unaffected by 100 μm 2 -O-Me-cGMP ( Fig. 3A and C; note that 2 -O-Me-cGMP fails to activate Epac; Kang et al. 2006) . It may be concluded that the inhibitory action of 2 -O-Me-cAMP reported here results from a selective interaction of this ESCA with a cAMP-binding protein that most likely corresponds to Epac.
-O-Me-cAMP acts independently of PKA to inhibit K ATP channel activity in INS-1 cells
Although ESCAs activate Epac in a selective manner, they have a limited ability to activate PKA when tested at concentrations in excess of 100 μm (Enserink et al. 2002) . However, such a PKA-mediated action of 2 -O-Me-cAMP is unlikely to explain the findings reported here. This conclusion is reached because 50 μm 2 -O-Me-cAMP inhibited K ATP channel activity under conditions in which the inner surfaces of excised patches were exposed to 100 μm Rp-cAMPS ( Fig. 4A and C) . Rp-cAMPS is a cAMP antagonist that blocks the activation of PKA by cAMP (Dostmann et al. 1990 ), but which fails to prevent the activation of Epac by ESCAs (Rangarajan et al. 2003; Holz et al. 2008a) . Interestingly, Rp-cAMPS, alone, inhibited INS-1 cell K ATP channel activity when patches were exposed to a fixed concentration (10 μm) of ATP (Fig. 4A and C) . In contrast, 6-Bnz-cAMP (100 μm), a cAMP analogue that activates PKA but not Epac (Christensen et al. 2003) , stimulated channel activity ( Fig. 4B and C) . Such findings suggest a dual action of cAMP, one in which channel activity is stimulated in a PKA-mediated manner, whereas channel activity is inhibited in an Epac-mediated manner. Consistent with this concept, we found that when patches were exposed to 10 μm ATP, a low concentration of cAMP (1 μm) increased the value of NP o by 20 ± 5% (mean ± s.e.m., n = 5 patches), whereas a high concentration of cAMP (300 μm) decreased the value of NP o by 88 ± 4% (n = 6 patches).
-O-Me-cAMP interacts cooperatively with ATP to inhibit K ATP channels in INS-1 cells
We next sought to determine to what extent 2 -O-Me-cAMP and ATP interact to inhibit K ATP J Physiol 586.5 channel activity. To this end, the action of 2 -O-Me-cAMP was assessed under conditions in which test solutions contained either no ATP or a fixed concentration of ATP. When patches were exposed to a test solution containing no ATP, 2 -O-Me-cAMP (50 μm) inhibited K ATP channel activity, but this action of the ESCA was slow in onset (Fig. 5A) . Thus, in the absence of 2 -O-Me-cAMP, the value of NP o measured in an ATP-free solution was 0.18 ± 0.03 and this value decreased to 0.06 ± 0.02 during a 40 s application of 2 -O-Me-cAMP. Subsequently, the value of NP o recovered to 0.13 ± 0.02 after washout of 2 -O-Me-cAMP (mean ± s.e.m., n = 5 patches). It may be concluded that the inhibitory action of 2 -O-Me-cAMP reported here is not strictly ATP-dependent. Despite this fact, when excised patches were exposed to a test solution containing both 2 -O-Me-cAMP and 30 μm ATP, a faster and stronger inhibition of K ATP channel activity was measured (Fig. 5B ). This interaction of 2 -O-Me-cAMP and ATP to inhibit K ATP channels resulted in a statistically significant difference when comparing values of NP o measured after a 10 s application of ATP, or after a 10 s application of ATP in the presence of 2 -O-Me-cAMP (Fig. 5C ). Fig. 6A and B) . For this analysis, values of NP o measured at different concentrations of ATP (1-300 μm) were normalized relative to the baseline channel activity measured in the presence of 0.3 μm ATP. Thus, for patches not exposed to 2 -O-Me-cAMP, a relative current value of 1.0 represents the channel activity measured in the presence of 0.3 μm ATP alone. For patches exposed to 2 -O-Me-cAMP, a relative current value of 1.0 represents the channel activity measured in the combined presence of 0.3 μm ATP and 50 μm 2 -O-Me-cAMP. Using this analysis, the concentration of ATP producing a 50% decrease of channel activity (IC 50 ) was determined to be 14 μm in the absence of 2 -O-Me-cAMP (Fig. 6B) . Remarkably, the IC 50 value for inhibition of K ATP channel activity by ATP decreased to 4 μm when patches were exposed to 50 μm 2 -O-Me-cAMP (Fig. 6B) .
-O-
Inhibition of K ATP channel activity by 2 -O-Me-cAMP in human pancreatic β-cells
The physiological relevance of Epac-mediated K ATP channel regulation was evaluated using human pancreatic β-cells maintained in primary cell culture. β-Cells were identified on the basis of rat insulin 2 gene promoter-directed expression of EYFP (Kang et al. 2003) and K ATP channel activity was monitored in excised inside-out patches. Similar to what was observed for INS-1 cells, 2 -O-Me-cAMP exerted a dose-dependent inhibitory action (IC 50 12 μm; data not shown) to reduce channel activity under conditions in which the concentration of ATP was maintained at 10 μm. Furthermore, a fixed concentration of 2 -O-Me-cAMP (50 μm) facilitated the inhibitory action of ATP at the channels (Fig. 7) . To evaluate the action of 2 -O-Me-cAMP in greater detail, the dose-response relationship describing ATP-dependent inhibition of K ATP channel activity was determined in the absence or presence of 2 -O-Me-cAMP. In the absence of 2 -O-Me-cAMP, the concentration of ATP producing a 50% inhibition of channel activity was 21 μm. However, in the presence of 50 μm 2 -O-Me-cAMP, a left-shift of the ATP dose-response relationship was observed, and under these conditions the concentration of ATP producing a 50% inhibition of channel activity was 1 μm (n = 6 patches).
PDE-resistant Sp-8-pCPT-2 -O-Me-cAMPS inhibits K ATP channel activity
PDE-catalysed hydrolysis of ESCAs can generate bioactive derivatives of adenosine, substances that alter cellular J Physiol 586.5 function independently of Epac (Laxman et al. 2006) . Such a confounding effect of cyclic nucleotide metabolism can complicate the interpretation of studies using ESCAs (Holz et al. 2008a ). This complication may be circumvented by validating that a PDE-resistant ESCA such as Sp-8-pCPT-2 -O-Me-cAMPS mimics the action of a PDE-sensitive ESCA (Laxman et al. 2006) . To validate that the inhibitory action of 2 -O-MecAMP reported here did not result from its hydrolysis to bioactive derivatives of adenosine, it was confirmed that Sp-8-pCPT-2 -O-Me-cAMPS inhibited K ATP channel activity in INS-1 cells under conditions in which excised patches were exposed to a fixed concentration (10 μm) of ATP ( Fig. 8A and B) . Values of NP o deduced from an all-points amplitude histogram (not shown) demonstrated that on average, 100 μm Sp-8-pCPT-2 -O-Me-cAMPS decreased K ATP channel activity by 72 ± 3% (Fig. 8C) .
Discussion
Evidence for Epac-mediated regulation of K ATP channel activity
Here the novel pharmacological properties of Epacselective cAMP analogues (ESCAs) have been exploited in order to assess the potential role of cAMP sensor Epac as a determinant of K ATP channel activity in human pancreatic β-cells and rat INS-1 cells. Using two structurally related ESCAs, 2 -O-Me-cAMP and Sp-8-pCPT-2 -O-Me-cAMPS, we document an inhibitory effect of ESCAs on the activity of K ATP channels at the single channel level. Such findings extend on our prior study of human β-cells and rat INS-1 cells in which the ESCA 8-pCPT-2 -O-Me-cAMP was demonstrated to inhibit a sulphonylurea-sensitive K + current measured under conditions of whole-cell recording . The main finding of the present study is that 2 -O-Me-cAMP sensitized single K ATP channels to the inhibitory effect of ATP, thereby reducing channel activity. This sensitizing action of the ESCA produced a left-shift of the dose-response relationship describing ATP-dependent inhibition of channel activity so that the concentration of ATP producing a 50% inhibition (IC 50 ) was reduced from approximately 22 μm to 1 μm for human β-cells, and from 14 to 4 μm for INS-1 cells. Conversely, under conditions in which the ATP concentration was held constant at 10 μm, 2 -O-Me-cAMP exerted a dose-dependent action to inhibit K ATP channel activity, an effect that was both reversible and repeatable. On the basis of such findings it is concluded that there exists a previously unrecognized form of ion channel modulation in which the ATP sensitivity of β-cell K ATP channels is regulated by Epac.
Interpretation of findings obtained using Sp-8-pCPT-2 -O-Me-cAMPS
Findings presented here are the first to demonstrate the efficacy of Sp-8-pCPT-2 -O-Me-cAMPS as an inhibitor of K ATP channel function. An assessment of the action of Sp-8-pCPT-2 -O-Me-cAMPS was deemed necessary because in studies of the protozoan Trypanosoma, Laxman et al. (2006) reported that 8-pCPT-2 -O-Me-cAMP (a PDE-sensitive ESCA) exerted an antiproliferative effect not mediated by Epac. Evidently, PDE converts 8-pCPT-2 -O-Me-cAMP to 8-pCPT-2 -O-Me-adenosine, a bioactive metabolite that exerts Epac-independent actions to alter cellular function. Thus, if the PDEs of β-cells or INS-1 cells were to also hydrolyse ESCAs, a PDE-sensitive ESCA such as 2 -O-Me-cAMP might act independently of Epac to inhibit K ATP channel function. However, such an Epac-independent mechanism of ESCA action is unlikely to explain the findings presented here. This conclusion is reached because we found that in INS-1 cells, PDE-resistant Sp-8-pCPT-2 -O-Me-cAMPS inhibited K ATP channel activity in a manner analogous to that of 2 -O-Me-cAMP. Laxman et al. (2006) also reported the surprising finding that the PDEs of Trypanosoma are inhibited by 8-pCPT-2 -O-Me-cAMP. Thus, if ESCAs were to inhibit the PDEs expressed in β-cells or INS-1 cells, the net effect might be increased levels of cAMP, activation of PKA, and the Epac-independent inhibition of K ATP channel function. This confounding scenario is unlikely for three reasons. First, Rp-cAMPS, a selective inhibitor of PKA activation, failed to antagonize the inhibitory action of 2 -O-Me-cAMP at the K ATP channels of INS-1 cells. Secondly, 6-Bnz-cAMP, a selective activator of PKA, failed to reproduce the action of 2 -O-Me-cAMP, and in fact 6-Bnz-cAMP stimulated rather than inhibited K ATP channel function. Third, in our prior study we reported that 8-pCPT-2 -O-Me-cAMP failed to inhibit the macroscopic K ATP current measured under conditions in which INS-1 cells were transfected with a dominant negative Epac1 that fails to bind cAMP. Thus, available evidence indicates that it is Epac rather than PKA that mediates the inhibitory action of ESCAs at K ATP channels.
A potential mechanistic explanation for K ATP channel regulation by Epac
The exact molecular mechanism by which cAMP, acting through Epac, alters K ATP channel ATP sensitivity remains to be determined. Epac is a cAMP-GEF, and it activates the Ras-related GTPases Rap1 and Rap2, thereby influencing multiple cellular functions (reviewed by Bos, 2003 Bos, , 2006 Holz, 2004a Holz, , 2008a . Notably, Epac is reported to act via Rap GTPase to stimulate a novel membrane-associated phospholipase C-ε that is expressed in INS-1 cells and which was first discovered by Kelley and coworkers (Kelley et al. 2001; G. G. Kelley, personal communication) . Phospholipase C-ε catalyses the breakdown of polyphosphoinositides and it has been implicated in the cAMP-dependent regulation of intracellular Ca 2+ handling in cardiac myocytes (Oestreich et al. 2007; Pereira et al. 2007 ) and in mammalian cell lines (Schmidt et al. 2001; Evellin et al. 2002) . Given the established role of phosphatidylinositol bisphosphate (PIP 2 ) as a regulator of K ATP channel function (Nichols, 2006) , and given that PIP 2 supports K ATP channel activity at least in part by reducing the channel's sensitivity to ATP (Baukrowitz et al. 1998; Shyng & Nichols, 1998) , a cAMP signalling mechanism that uses Epac, Rap, and phospholipase C-ε to reduce levels of PIP 2 in the plasma membrane would be expected to increase the sensitivity of K ATP channels to ATP. Thus, the SUR1 subunit of K ATP channels might be viewed as a scaffold protein at which a signalling complex comprising Rap and phospholipase C-ε forms as a consequence of the interaction of Epac with NBF-1 of SUR1. It will be of particular interest to ascertain in future studies to what extent the targeted gene deletion of phospholipase C-ε alters cAMP signalling and K ATP channel function in β-cells.
Physiological significance of Epac-mediated K ATP channel regulation
Numerous reports have recently appeared in which Epac is proposed to mediate stimulatory actions of cAMP on insulin secretion from β-cells (Seino & Shibasaki, 2005; Holz et al. 2006; Shibasaki et al. 2007 ). This Epac-mediated action of cAMP does not exist in isolation, but is instead complemented by a stimulatory effect of cAMP that is mediated by PKA (Holz, 2004a) . Importantly, both the Epac and PKA-mediated pro-secretagogue actions of cAMP are known to be contingent on exposure of β-cells to elevated concentrations of glucose. This observation has led to the conclusion that cAMP exerts its secretagogue action by potentiating glucose-stimulated insulin secretion (GSIS). From a theoretical standpoint, cAMP could potentiate GSIS at either a late or an early step in stimulus-secretion coupling. In fact, a late step does exist in which cAMP, acting through Epac and PKA, facilitates the fusion of secretory granules with the plasma membrane (Renstrom et al. 1997; Takahashi et al. 1999; Kashima et al. 2001; Fujimoto et al. 2002; Eliasson et al. 2003; Hatakeyama et al. 2006 Hatakeyama et al. , 2007 . In marked contrast, evidence also exists that cAMP potentiates GSIS at an earlier step, one that involves the regulated closure of K ATP channels. In one proposed model, cAMP acts through Epac and PKA to render K ATP channels more sensitive to the increase of cytosolic ATP/ADP concentration ratio that occurs when β-cells are exposed to high levels of glucose (Holz, 2004b) . This effect is achieved because cAMP promotes K ATP channel closure by modulating the ATP and/or ADP sensitivity of K ATP channels. The model is supported by published findings demonstrating inhibitory actions of cAMP-elevating agents at K ATP channels, effects that are reinforced by glucose metabolism, and which are either ATP or ADP dependent (Holz & Habener, 1992; Holz et al. 1993; Barnett et al. 1994; Gromada et al. 1998; He et al. 1998; Suga et al. 2000; Ding et al. 2001; Light et al. 2002; Kang et al. 2006) .
With these points in mind, the primary physiological significance of the findings presented here is that an Epac-mediated mechanism is shown to exist by which cAMP regulates the ATP sensitivity of K ATP channels in human β-cells and rat INS-1 cells. Whether such findings are applicable to rat or mouse β-cells remains to be determined. This might be the case because in a prior study of rat β-cells, Suga et al. (2000) found that the cAMP-elevating hormone glucagon-like peptide-1 (GLP-1) increased the sensitivity of single K ATP channels to ATP, an effect analogous to that reported here for 2 -O-Me-cAMP. This action of GLP-1, which resulted in a decrease of membrane conductance accompanied by membrane depolarization, was not blocked by Rp-cAMPS, as expected if it is Epac rather than PKA that regulates K ATP channel ATP sensitivity.
In the study of Suga and coworkers the IC 50 value for inhibition of K ATP channel activity by ATP was 11.6 μm in the absence of GLP-1, and 5.6 μm in the presence of GLP-1 (Suga et al. 2000) . Thus, in the presence of GLP-1, the IC 50 value describing the inhibitory action of ATP at rat β-cell K ATP channels is nearly identical to the IC 50 value (4 μm) we measured under conditions in which the K ATP channels of rat INS-1 cells were exposed to 2 -O-Me-cAMP. Although these IC 50 concentrations of ATP are well below the millimolar concentrations of ATP known to exist in the cytosol of intact cells, it is noteworthy that our findings, as well as those of Suga and coworkers, were obtained under conditions in which the inner surfaces of excised patches were exposed to a bath solution to which no Mg-ADP was added. Since Mg-ADP stimulates K ATP channel function, and since Mg-ADP is present in the cytosol of intact cells, it might be that in the presence of Mg-ADP, agents such as GLP-1 or 2 -O-Me-cAMP increase K ATP channel ATP sensitivity at concentrations of ATP that are within the millimolar range and which are considered to be physiological.
Although not examined here, cAMP-elevating agents may also regulate the ADP sensitivity of K ATP channels. In a mammalian cell line expressing recombinant Kir6.2 and SUR1, Light and coworkers reported that application of the catalytic subunit of PKA (cPKA) to inside-out patches bathed in a low concentration of Mg-ADP (0.2 mm) resulted in a decrease of K ATP channel activity (Light et al. 2002) . In that study, the ATP sensitivity of K ATP channels was not affected by cPKA, whereas the stimulatory effect of 0.2 mm Mg-ADP at the channel was diminished by cPKA. It was suggested that cAMP-elevating agents such as GLP-1 close K ATP channels by reducing the channel's sensitivity to Mg-ADP. Taken together, the findings of Light and coworkers, as well as the findings presented here, provide evidence for an action of cAMP to decrease K ATP channel activation by ADP while simultaneously increasing the channel's inhibition by ATP. Such an effect would be expected to render K ATP channels highly sensitive to the increase of cytosolic ATP/ADP concentration ratio that occurs upon exposure of β-cells to elevated levels of glucose. In this manner, GLP-1 and glucose metabolism would interact to promote membrane depolarization and Ca 2+ influx, two key events in β-cell stimulus-secretion coupling (Holz et al. 2008b ).
Conclusion
The emerging role of the cAMP sensor Epac as a regulator of ion channel function is an unexpected and exciting development. The potential significance of this newly recognized mechanism of cAMP signal transduction is emphasized by the fact that Epac influences not only K ATP channel function, as reported here, but also the function of voltage-dependent Ca 2+ channels, Cl − channels, Na + channels, and Ca 2+ -dependent K + channels in a variety of cell types (Novara et al. 2004; Aromataris et al. 2006; Helms et al. 2006; Ster et al. 2007 ). There is also evidence for the Epac-mediated regulation of intracellular Ca 2+ release channels, including IP 3 receptors and ryanodine receptors (Kang et al. 2001 (Kang et al. , 2003 (Kang et al. , 2005 Schmidt et al. 2001; Tsuboi et al. 2003; Morel et al. 2005; Yip, 2006; Oestreich et al. 2007; Pereira et al. 2007 ). Thus, it would seem that a new paradigm of ion channel modulation has been established in which the second messenger cAMP exerts its effects via Epac.
